What Ecovamed does

Ecovamed is a French life cycle assessment (LCA) and carbon footprint services company founded in 2021, headquartered in Chaville (Paris region) and incubated at Chimie Paris Innov within Université Paris Sciences et Lettres. The company specializes in evaluating and reducing the environmental footprint of medicines, medical devices, pharmaceutical active ingredients and intermediates, and bio-based chemicals and natural products, using a proprietary methodology combined with purpose-built databases that assess manufacturing processes and geographical origin of drug substances across the supply chain, with significant process automation enabling cost-competitive delivery.

The company's product surface comprises five offerings: a tailor-made Carbon Footprint and LCA service for health products and chemicals compliant with GHG Protocol and ISO 14040-14044 (covering up to 16 environmental impacts); a Corporate and Site Carbon Accounting service supporting CDP, SBTi and French BEGES compliance with rigorous Scope 3 evaluation; an LCA service for full healthcare pathways; the Single-use vs Reusable Carbon Footprint Calculator for medical devices, offered free as a top-of-funnel acquisition tool; and the Medicine Carbon Footprint Database, described as the first database containing carbon footprints of all oral and injectable medicines from the French pharmacopoeia, with assessed uncertainty and category-level breakdowns. Database access is free for hospital medical doctors and pharmacists and sold via annual subscription to other stakeholders.

Ecovamed monetizes through three streams: annual database subscriptions (recurring), tailor-made LCA and carbon footprint consulting (professional services), and corporate carbon accounting engagements (professional services), distributed via a self-serve web platform, a freemium calculator, and direct sales through the website contact form targeting pharmaceutical, biotech, medical device, and chemical companies. The company is led by founder-Président Sébastien Taillemite, operates with a 6-person team, and has received a BPI France Bourse French Tech grant; it has published a sustained cadence of peer-reviewed methodology studies since 2021 to establish scientific credibility.

Name

Ecovamed

Legal name

ECOVAMED, Société par Actions Simplifiée

Website

https://ecovamed.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Ecovamed is a French Life Cycle Assessment company that provides carbon footprint and multi-impact LCA services, a medicine carbon footprint database, and a free single-use vs reusable medical device calculator for pharmaceutical, medical device, chemical, and healthcare customers.

Ownership category

akta.pro rank

Product category

Environmental Consulting Services

NAICS

Environmental Consulting Services (541620)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Emissions Factors, LCA & Product Carbon Footprint (PCF) Platforms (EUABAEAD)

akta.pro secondary industries

Product Sustainability & LCA/EPD (Eco-design, PCF) (EUAHAJAF), ESG/Sustainability Reporting & Disclosure Platforms (EUABAEAB), Enterprise Carbon Accounting & GHG Inventory Platforms (EUABAEAA), Greenhouse Gas (GHG) & Climate Regulatory Compliance (Mandatory Reporting, Cap-and-Trade Compliance) (EUAHABAG)

Keywords

• Life cycle assessment
• Carbon footprint consulting
• Pharmaceutical sustainability
• Environmental impact analysis
• Medicines carbon database

Headquarters

HQ city

Chaville

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Medicine Carbon Footprint Database Subscription: Annual subscription fee for access to the medicine carbon footprint database, with free access provided to hospital medical doctors and pharmacists engaged in healthcare pathways eco-design. Other stakeholders pay an annual subscription.
2. Custom Carbon Footprint and LCA Services: Tailor-made carbon footprint evaluations and multi-impact LCA consulting services sold at competitive pricing to pharmaceutical, chemical, and medical device manufacturers. Also includes tailor-made requests for sub-categories such as Active Pharmaceutical Ingredient carbon footprints.
3. Corporate Carbon Accounting Services: Corporate carbon accounting services performed according to GHG Protocol standard for CDP and SBTi projects, and complying with French BEGES regulation. Includes scope 3 evaluation and supply-chain engagement for emission reduction.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Ecovamed provides Life Cycle Assessment (LCA) and carbon footprint evaluation services for medicines, medical devices, pharmaceutical ingredients, biologics, (bio)chemicals, natural products, and materials, compliant with GHG Protocol and ISO 14040-14044 standards. It operates a proprietary Medicine Carbon Footprint Database covering the French pharmacopoeia and a free single-use vs reusable medical device carbon footprint calculator, complemented by tailor-made corporate carbon accounting for CDP, SBTi, and French BEGES compliance.

Product overview

Ecovamed offers an innovative Life Cycle Assessment (LCA) solution platform focused on evaluating and reducing the environmental footprint of medicines, medical devices, pharmaceutical ingredients, and bio-based chemicals. The core offerings include: (1) a Carbon Footprint and LCA Service for health products and chemicals using GHG Protocol and ISO 14040-14044 standards; (2) a Medicine Carbon Footprint Database covering all oral and injectable medicines from the French pharmacopoeia; (3) a free Single-use vs. Reusable Carbon Footprint Calculator for comparing medical device environmental impacts; (4) Corporate and Site Carbon Accounting for CDP, SBTi, and French BEGES compliance; and (5) Healthcare Pathway LCA services. The platform is designed for pharmaceutical, biotech, chemical companies, and healthcare professionals seeking to assess and reduce environmental impacts.

Differentiator

Problem solved

Functional benefit

Brands

• Medicine Carbon Footprint Database: First database with carbon footprints of all oral and injectable medicines from the French pharmacopoeia
• Single-use vs. Reusable Carbon Footprint Calculator

Products and services

• Medicine Carbon Footprint Database A searchable database subscription product containing carbon footprints of all oral and injectable medicines from the French pharmacopoeia, with assessed uncertainty and breakdown across raw materials, manufacturing, and distribution. Free access is provided to hospital medical doctors and pharmacists engaged in healthcare pathways eco-design; other stakeholders pay an annual subscription.
• Single-use vs. Reusable Carbon Footprint Calculator A free web application that compares the carbon footprints of single-use medical devices versus reusable devices with steam sterilization, covering material type, mass, country of origin, pre-disinfection, washing/sterilization processes, sterilization packaging, and end-of-life waste management.
• Carbon Footprint and LCA of Health Products and Chemicals Tailor-made carbon footprints complying with the GHG Protocol standard and multi-impact LCA conforming with ISO 14040-14044, specializing in active pharmaceutical ingredients, intermediates, (bio)chemicals, and natural products for medicines LCA. Covers up to 16 environmental impacts.
• Corporate and Site Carbon Accounting Corporate and site carbon accounting performed according to GHG Protocol for CDP and SBTi projects and complying with French BEGES regulation, including rigorous scope 3 evaluation covering purchasing of goods and services, waste treatment, and capital goods, with supply-chain engagement for scope 3 reduction.
• Life Cycle Assessment of Healthcare Pathways LCA services for full patient pathways covering infrastructure (energy, fugitive emissions, capital goods, buildings), transport (patient, professionals, products), health products (medicines, medical devices), and waste treatment to identify key environmental impact contributors across care pathways such as surgeries, telemedicine, outpatient care, eco-prescription, and chemotherapy.

Quantifiable outcome

• Recycling PVC-based medical device cuts greenhouse gas emissions by 25% compared to incineration
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Chimie Paris Innov (PSL)coreStrategic or Co-development PartnerEcovamed is incubated at Chimie Paris Innov within the University Paris Sciences et Lettres (PSL) environment, providing access to academic resources and innovation infrastructure to support continued development of the company's technology.
• ChemTech (France Chimie and Bpifrance)minorStrategic or Co-development PartnerEcovamed joined ChemTech, a joint initiative of France Chimie and Bpifrance to support startups developing chemical-oriented solutions. ChemTech is a network of innovative startups in the chemical sector.
• G5 SantéminorOthersEcovamed attended the 10th G5 Santé meeting held in Paris, an event bringing together stakeholders to debate on health innovation and sovereignty. G5 Santé is a coalition of French healthcare companies.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Sphera: Enterprise sustainability and LCA software platform with product-level carbon footprint capabilities. Comparable to Ecovamed as a SaaS/consulting provider of LCA and carbon accounting for industrial and life-science customers, though with a much broader portfolio and customer base.
• Watershed: Enterprise carbon accounting platform serving large corporates including regulated industries. Comparable to Ecovamed in corporate carbon accounting and scope 3 support, but operates as a generalist at significantly greater scale.
• EcoAct (Accenture): Sustainability consultancy providing carbon accounting, LCA, and SBTi/CDP advisory, now part of Accenture. Comparable to Ecovamed for corporate and product carbon footprint consulting, though with broader service lines and global delivery capacity.
• ERM (Environmental Resources Management): Global sustainability consultancy with deep life-sciences practice, providing LCA, EHS, and product sustainability services. Comparable to Ecovamed for pharmaceutical and chemical LCA consulting, though at enterprise scale with broader geographic reach.

Emerging players

• Normative: Carbon accounting software platform focused on Scope 3 and product-level emissions. Comparable to Ecovamed for its database-driven approach to emissions factors and corporate carbon accounting, though with broader scope than pharma.
• Sweep: Carbon accounting and sustainability platform with strong Scope 3 and supplier engagement features. Comparable to Ecovamed for its carbon accounting SaaS with emphasis on supply-chain emission data and reduction workflows.
• Greenly: Carbon accounting platform combining software and consulting for SMBs and enterprises. Comparable to Ecovamed for carbon accounting services and methodology-led footprinting, though targeting a broader customer base.

Direct peers

• Carbon Trust: Independent sustainability consultancy offering product carbon footprinting, LCA, and corporate carbon accounting. Directly comparable to Ecovamed for its bespoke LCA services and methodology-driven product footprinting work.
• Quantis (now part of BCG): Sustainability consultancy specialising in product-level LCA, environmental footprinting, and Scope 3 strategy for consumer goods, food, and pharma. Directly comparable to Ecovamed in offering LCA and carbon footprint services, including pharmaceutical sustainability work.
• PRé Sustainability: LCA consultancy and developer of SimaPro LCA software, with deep expertise in product sustainability and pharma/chemicals. Comparable to Ecovamed for ISO 14040-conformant product LCA services and database-driven sustainability assessments.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ecovamed

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ecovamed